Multimodality US Based on Angio Planewave Ultrasensitive Imaging and Shear Wave Elastography to Evaluate the Malignancy Risk Value of Thyroid Nodules
1 other identifier
observational
720
1 country
1
Brief Summary
The goal of this clinical trial is to explore the value of a multimodal ultrasound model based on Angio Planewave Ultrasensitive Imaging, Shear Wave Elastography and grayscale ultrasound in the differential diagnosis of benign and malignant thyroid nodules. The main questions it aims to answer are: Can an innovative ultra-microvascular classification system based on Angio Planewave Ultrasensitive Imaging distinguish between benign and malignant thyroid nodules? How about the performance of multimodal ultrasound model to Guide the Fine-Needle Aspiration Management of Thyroid Lesions? Participants will: Undergo grayscale ultrasound, SWE, and Angio Planewave Ultrasensitive Imaging multimodal thyroid ultrasound examination within one week before surgery Undergo surgery and obtain the postoperative pathological diagnosis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 29, 2024
CompletedFirst Posted
Study publicly available on registry
July 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedJuly 31, 2024
December 1, 2023
2.4 years
July 29, 2024
July 30, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Diagnostic efficacy
the area under the receiver operating characteristic (ROC) curve (AUC)
one week
Diagnostic efficacy
sensitivity, specificity, accuracy
one week
positive predictive value (PPV), and negative predictive value (NPV)
Diagnostic efficacy
one week
Study Arms (2)
Malignant thyroid nodules
Benign thyroid nodules
Interventions
Conventional US, SWE, and AP of thyroid nodules were conducted successively with a Supersonic Aixplorer system (SuperSonic Imagine, Aix-en-Provence, France) using a 5-14 MHz linear transducer.
Eligibility Criteria
Population data for this prospective single-center cohort study were gathered at the Fifth Affiliated Hospital of Sun Yat-sen University.
You may qualify if:
- age more than 18 years;
- Voluntarily signed informed consent;
- Have 1 or more thyroid nodules detectable by ultrasound;
- participant underwent surgical procedure to confirm the pathologic results
You may not qualify if:
- Nodules are accompanied by large calcifications followed by acoustic shadows
- History of previous neck surgery or cancer, thyroid medications, radiation or surgical treatment;
- Poor quality of retained images or non-standard operations (such as intermittent scanning and improper probe compression), and incomplete pathological results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Fifth Affiliated Hospital Sun Yat-Sen University
Zhuhai, Guangdong, 519000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2024
First Posted
July 31, 2024
Study Start
July 1, 2022
Primary Completion
November 30, 2024
Study Completion
December 30, 2024
Last Updated
July 31, 2024
Record last verified: 2023-12